PMID: 6971704Apr 1, 1981Paper

Glucocorticoid receptors and terminal deoxynucleotidyl transferase activities in leukemic cells

Cancer
Y NakaoS Watanabe

Abstract

Glucocorticoid (GC) receptor and terminal deoxynucleotidyl transferase (TdT) activities were studied in leukemia cells to investigate their diagnostic and therapeutic implications. Among cell lines with T-cell character, higher GC-receptor and TdT activities were found in T-ALL (HPB-ALL and ALL-Ichikawa) than in cells from adult pleomorphic T-cell leukemia (HPB-MLT). HPB-Null with pre-B cell-character exhibited moderate GC receptor but low TdT activity; Raji cells and CCRF-SB, derived from B-cell Burkitt lymphoma and B-ALL, respectively, manifested low GC receptor and no TdT activity. The highest GC receptor activity was demonstrated in null-cell ALL, followed, in order, by juvenile T-ALL, adult pleomorphic T-cell leukemia, and AML. Other kinds of lymphoid and monocytic leukemias exhibited low GC receptor and no TdT activity. Although low GC receptor and negative TdT were demonstrated in cells from seven out of nine patients under CML blastic crisis, the last patient had cells with positive TdT and GC receptor activity.

References

Mar 6, 1976·Lancet·R D BarrS M Perry
Feb 15, 1978·International Journal of Cancer. Journal International Du Cancer·S MorikawaK Yasuhira
Jun 1, 1978·Journal of the National Cancer Institute·J MinowadaE Tatsumi
May 1, 1977·The Journal of Clinical Investigation·M F GreenwoodP Holland
Feb 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·I GoldschneiderF J Bollum
May 1, 1978·The American Journal of Medicine·P C KungD Baltimore
Apr 10, 1975·The New England Journal of Medicine·R McCaffreyD Baltimore
Apr 10, 1975·The New England Journal of Medicine·R C Gallo
Feb 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·R McCaffreyD Baltimore
Jul 1, 1973·The Journal of Clinical Investigation·M E LippmanE B Thompson
Nov 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·M S ColemanF J Bollum
Jan 25, 1973·The New England Journal of Medicine·W F PiessensW H Churchill
Jun 18, 1974·Biochemical and Biophysical Research Communications·M S ColemanF J Bollum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
E M van den DoelG E Staal
International Journal of Radiation Oncology, Biology, Physics
E D Werts, K M Smith
© 2021 Meta ULC. All rights reserved